Effective use of mass spectrometry in the clinical laboratory

Clinical Chemistry

Volumn 62, Issue 1, 2016, Pages 92-98

  Jannetto, Paul J ^a   Fitzgerald, Robert L ^b  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

3 HYDROXYBUTYRIC ACID; C PEPTIDE; TESTOSTERONE; THYROGLOBULIN; VITAMIN D; DRUG; STEROID; STREET DRUG;

CLINICAL LABORATORY; DRUG MONITORING; HUMAN; LABORATORY TEST; LIQUID CHROMATOGRAPHY; MASS FRAGMENTOGRAPHY; MASS SPECTROMETRY; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; REIMBURSEMENT; REVIEW; TANDEM MASS SPECTROMETRY; CLINICAL MEDICINE; NEWBORN; NEWBORN SCREENING;

CLINICAL LABORATORY TECHNIQUES; CLINICAL MEDICINE; HUMANS; INFANT, NEWBORN; MASS SPECTROMETRY; NEONATAL SCREENING; PHARMACEUTICAL PREPARATIONS; STEROIDS; STREET DRUGS;

EID: 84954470372     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2015.248146     Document Type: Review

References (42)

1. Irving J. Drug testing in the military-technical and legal problems. Clin Chem 1988;34:637-40.
2. Millington DS, Kodo N, Norwood DL, Roe CR. Tandem mass spectrometry: a new method for acylcarnitine profiling with potential for neonatal screening for inborn errors of metabolism. J Inherit Metab Dis 1990;13:321-4.
3. Fitzgerald RL, Herold DA. Serum total testosterone: immunoassay compared with negative chemical ionization gas chromatography-mass spectrometry. Clin Chem 1996;42:749-55.
4. Holland RD, Wilkes JG, Rafii F, Sutherland JB, Persons CC, Voorhees KJ, et al. Rapid identification of intact whole bacteria based on spectral patterns using matrixassisted laser desorption/ionization with time-of-flight mass spectrometry. Rapid Commun Mass Spectrom 1996;10:1227-32.
5. Gero D. Military aviation disasters: significant losses since 1908. Yeovil Somerset: Haynes Publications; 1999.
6. Reagan R. Executive Order 12564 - drug-free federal workplace; 1986. p 224. http://www.archives.gov/federal-register/codification/executive-order/12564.html (Accessed October 2015).
7. US Government Publishing Office. Mandatory guidelines for federal workplace drug testing. Federal Register 1998;63(219):11970. http://www.gpo.gov/fdsys/granule/FR-1998-11-13/98-30403 (Accessed October 2015).
8. Peat MA. Financial viability of screening for drugs of abuse. Clin Chem 1995;41:805-8.
9. Miller TR, Zaloshnja E, Spicer RS. Effectiveness and benefit-cost of peer-based workplace substance abuse prevention coupled with random testing. Accid Anal Prev 2007;39:565-73.
10. Taieb J, Mathian B, Millot F, Patricot MC, Mathieu E, Queyrel N, et al. Testosterone measured by 10 immunoassays and by isotope-dilution gas chromatographymass spectrometry in sera from 116 men, women, and children. Clin Chem 2003;49:1381-95.
11. Bayliss MK, Little D, Mallett DN, Plumb RS. Parallel ultra-high flow rate liquid chromatography with mass spectrometric detection using a multiplex electrospray source for direct, sensitive determination of pharmaceuticals in plasma at extremely high throughput. Rapid Commun Mass Spectrom 2000;14:2039-45.
12. Clark AE, Kaleta EJ, Arora A, Wolk DM. Matrix-assisted laser desorption ionization-time of flight mass spectrometry: a fundamental shift in the routine practice of clinical microbiology. Clin Microbiol Rev 2013;26:547-603.
13. Tan KE, Ellis BC, Lee R, Stamper PD, Zhang SX, Carroll KC. Prospective evaluation of a matrix-assisted laser desorption ionization-time of flight mass spectrometry system in a hospital clinical microbiology laboratory for identification of bacteria and yeasts: a bench-by-bench study for assessing the impact on time to identification and cost-effectiveness. J Clin Microbiol 2012;50:3301-8.
14. Patel R. MALDI-TOF MS for the diagnosis of infectious diseases. Clin Chem 2015;61:100-11.
15. Gekenidis MT, Studer P, Wuthrich S, Brunisholz R, Drissner D. Beyond the matrix-assisted laser desorption ionization (MALDI) biotyping workflow: in search of microorganism-specific tryptic peptides enabling discrimination of subspecies. Appl Environ Microbiol 2014;80:4234-41.
16. Ecker DJ, Sampath R, Li H, Massire C, Matthews HE, Toleno D, et al. New technology for rapid molecular diagnosis of bloodstream infections. Expert Rev Mol Diagn 2010;10:399-415.
17. Aichler M, Walch A. MALDI Imaging mass spectrometry: current frontiers and perspectives in pathology research and practice. Lab Invest 2015;95:422-31.
18. Norris JL, Caprioli RM. Analysis of tissue specimens by matrix-assisted laser desorption/ionization imaging mass spectrometry in biological and clinical research. Chem Rev 2013;113:2309-42.
19. Balluff B, Frese CK, Maier SK, Schone C, Kuster B, Schmitt M, et al. De novo discovery of phenotypic intratumour heterogeneity using imaging mass spectrometry. J Pathol 2015;235:3-13.
20. Sun N, Ly A, Meding S, Witting M, Hauck SM, Ueffing M, et al. High-resolution metabolite imaging of light and dark treated retina using MALDI-FTICR mass spectrometry. Proteomics 2014;14:913-23.
21. Roberts LD, Souza AL, Gerszten RE, Clish CB. Targeted metabolomics. Curr Protoc Mol Biol. 2012; Chapter 30: Unit 30 2 1-24.
22. Gillette MA, Carr SA. Quantitative analysis of peptides and proteins in biomedicine by targeted mass spectrometry. Nat Methods 2013;10:28-34.
23. Nikolskiy I, Mahieu NG, Chen YJ, Tautenhahn R, Patti GJ. An untargeted metabolomic workflow to improve structural characterization of metabolites. Anal Chem 2013;85:7713-9.
24. Huang X, Chen YJ, Cho K, Nikolskiy I, Crawford PA, Patti GJ. ×13CMS: global tracking of isotopic labels in untargeted metabolomics. Anal Chem 2014;86:1632-9.
25. Handelsman DJ, Wartofsky L. Requirement for mass spectrometry sex steroid assays in the Journal of Clinical Endocrinology and Metabolism. J Clin Endocrinol Metab 2013;98:3971-3.
26. Ketha H, Kaur S, Grebe SK, Singh RJ. Clinical applications of LC-MS sex steroid assays: evolution of methodologies in the 21st century. Curr Opin Endocrinol Diabetes Obes 2014;21:217-26.
27. Cawood ML, Field HP, Ford CG, Gillingwater S, Kicman A, Cowan D, et al. Testosterone measurement by isotope-dilution liquid chromatography-tandem mass spectrometry: validation of a method for routine clinical practice. Clin Chem 2005;51:1472-9.
28. Wang Y, Gay GD, Botelho JC, Caudill SP, Vesper HW. Total testosterone quantitative measurement in serum by LC-MS/MS. Clin Chim Acta 2014;436:263-7.
29. Kushnir MM, Rockwood AL, Roberts WL, Abraham D, Hoofnagle AN, Meikle AW. Measurement of thyroglobulin by liquid chromatography-tandem mass spectrometry in serum and plasma in the presence of antithyroglobulin autoantibodies. Clin Chem 2013;59:982-90.
30. Clarke NJ, Zhang Y, Reitz RE. A novel mass spectrometry-based assay for the accurate measurement of thyroglobulin from patient samples containing antithyroglobulin autoantibodies. J Investig Med 2012;60:1157-63.
31. Netzel BC, Grebe SK, Algeciras-Schimnich A. Usefulness of a thyroglobulin liquid chromatographytandem mass spectrometry assay for evaluation of suspected heterophile interference. Clin Chem 2014;60:1016-8.
32. Hermida J, Tutor JC. Falsely increased blood tacrolimus concentrations using the ACMIA assay due to circulating endogenous antibodies in a liver transplant recipient: a tentative approach to obtaining reliable results. Ther Drug Monit 2009;31:269-72.
33. Rostaing L, Cointault O, Marquet P, Josse AG, Lavit M, Saint-Marcoux F, et al. Falsely elevated whole-blood tacrolimus concentrations in a kidney-transplant patient: potential hazards. Transpl Int 2010;23:227-30.
34. Moscato D, Nonnato A, Adamo R, Vancheri M, Caropreso A. Therapeutic monitoring of tacrolimus: aberrant results by an immunoassay with automated pretreatment. Clin Chim Acta 2010;411:77-80.
35. Adaway JE, Keevil BG. Therapeutic drug monitoring and LC-MS/MS. J Chromatogr B Analyt Technol Biomed Life Sci 2012;883-884:33-49.
36. Parfitt C, Church D, Armston A, Couchman L, Evans C, Wark G, McDonald TJ. Commercial insulin immunoassays fail to detect commonly prescribed insulin analogues. Clin Biochem 2015;48:1354-7.
37. Fitzgerald RL, Herold DA, Yergey AL. Trade-offs in mass spectrometry. Clin Chem 1997;43:915.
38. Netzel BC, Grebe SK, Carranza Leon BG, Castro MR, Clark PM, Hoofnagle AN, et al. Thyroglobulin (Tg) Testing Revisited: Tg Assays, TgAb Assays, and Correlation of Results With Clinical Outcomes. J Clin Endocrinol Metab 2015;100:E1074-83.
39. FDA. Guidance, compliance and regulatory information (biologics). www.fda.gov/BiologicsBloodVaccines/GuidanceComplianceRegulatoryInformation/default. htm (Accessed April 2015).
40. Xu W, Manicke NE, Cooks GR, Ouyang Z. Miniaturization of mass spectrometry analysis systems. JALA Charlottesv Va 2010;15:433-9.
41. Adaway JE, Keevil BG, Owen LJ. Liquid chromatography tandem mass spectrometry in the clinical laboratory. Ann Clin Biochem 2015;52:18-38.
42. Murray D, Barnidge D. Characterization of immunoglobulin by mass spectrometry with applications for the clinical laboratory. Crit Rev Clin Lab Sci 2013;50:91-102.